HELENA Study: An Observational Study of Perjeta (Pertuzumab) in First-Line Treatment in Patients With Her2-Positive Advanced Breast Cancer After Adjuvant Herceptin Therapy
N/A
This observational study will evaluate the efficacy, safety and patient rep...
Status
Completed
Location
AGAPLESION Markus-Krankenhaus
Start Date
2013-06-14
Trial ID
NCT01777958
Can the Vascular Physician Sensitize Patients to Redaction of Advance Directives on End of Life?
N/A
The Leonetti law of 22 April 2005 on the rights of patients at end of life ...